Medicare Enrolled
Dr. Mamta Choksi, M.D.
Hematology · Trinity, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Choksi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choksi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Choksi
Dr. Mamta Choksi is a hematology in Trinity, FL, with 20 years in practice. Based on federal Medicare data, Dr. Choksi performed 62,990 Medicare services across 2,410 unique beneficiaries.
Between the years covered by Open Payments, Dr. Choksi received a total of $34,283 from 97 pharmaceutical and/or device companies across 1153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Choksi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ 62,990 Medicare services$ $34,283 industry payments
Medicare Practice Summary
Medicare Utilization ↗62,990
Medicare services
Bottom 41% in FL for hematology
2,410
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 36,720 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia | 6,890 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $18 | $51 |
| Pembrolizumab injection (Keytruda) | 4,600 | $44 | $137 |
| Anti-nausea injection (aprepitant) | 2,600 | $1 | $5 |
| Blood draw (venipuncture) | 1,200 | $8 | $9 |
| Complete blood count (CBC) with differential | 1,192 | $8 | $29 |
| Drug injection, under skin or into muscle | 705 | $10 | $69 |
| Dexamethasone injection (steroid) | 654 | $0 | $3 |
| Office visit, established patient (30-39 min) | 577 | $96 | $339 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 350 | $1 | $6 |
| Office visit, established patient (20-29 min) | 276 | $62 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 250 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 200 | $0 | $9 |
| Injection of additional new drug or substance into vein | 170 | $11 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 145 | $96 | $378 |
| Injection, zoledronic acid, 1 mg | 145 | $7 | $69 |
| Red blood count automated, with additional calculations | 118 | $5 | $20 |
| Prothrombin time test (blood clotting) | 116 | $4 | $15 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 112 | $45 | $189 |
| Hospital follow-up visit, high complexity | 77 | $94 | $285 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 62 | $22 | $84 |
| Injection of drug or substance into vein | 59 | $28 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 58 | $3 | $11 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 48 | $16 | $59 |
| Administration of chemotherapy into vein, each additional hour | 44 | $21 | $79 |
| New patient office visit (45-59 min) | 44 | $112 | $453 |
| Injection, diphenhydramine hcl, up to 50 mg | 44 | $1 | $3 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 43 | $26 | $89 |
| Initial hospital admission, high complexity | 35 | $137 | $556 |
| Administration of additional new drug or substance into vein, 1 hour or less | 28 | $49 | $178 |
| Infusion into a vein for hydration, each additional hour | 26 | $9 | $42 |
| Infusion, normal saline solution , 1000 cc | 25 | $2 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 21 | $23 | $156 |
| Automated urinalysis | 16 | $2 | $8 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
58.7% high complexity
35.4% medium
5.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,283
Total received (2018-2024)
Avg $4,898/year across 7 years
Top 13% in FL for hematology
97
Companies
1,153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,087 (49.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$11,733 (34.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,462 (15.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,025
2023$11,248
2022$2,550
2021$3,644
2020$3,210
2019$7,121
2018$3,486
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ImmunoGen, Inc.
$7,742
Verastem, Inc.
$3,284
Celgene Corporation
$2,696
Bayer HealthCare Pharmaceuticals Inc.
$2,349
ARRAY BIOPHARMA INC
$2,012
Novartis Pharmaceuticals Corporation
$1,619
E.R. Squibb & Sons, L.L.C.
$1,454
Janssen Biotech, Inc.
$1,260
Genentech USA, Inc.
$860
AstraZeneca Pharmaceuticals LP
$711
PFIZER INC.
$694
Amgen Inc.
$565
GENZYME CORPORATION
$523
TerSera Therapeutics LLC
$521
Gilead Sciences, Inc.
$473
Merck Sharp & Dohme LLC
$425
Incyte Corporation
$419
Seagen Inc.
$417
Exelixis Inc.
$398
Lilly USA, LLC
$362
Daiichi Sankyo Inc.
$358
Merck Sharp & Dohme Corporation
$319
BeiGene USA, Inc.
$270
GlaxoSmithKline, LLC.
$251
Takeda Pharmaceuticals U.S.A., Inc.
$224
AbbVie Inc.
$191
Kite Pharma, Inc.
$187
Regeneron Healthcare Solutions, Inc.
$174
ABBVIE INC.
$161
Pharmacyclics LLC, An AbbVie Company
$142
EMD Serono, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$127
Astellas Pharma US Inc
$120
Adaptive Biotechnologies Corporation
$119
Rigel Pharmaceuticals, Inc.
$116
Agios Pharmaceuticals, Inc.
$112
Mirati Therapeutics, Inc.
$104
PUMA BIOTECHNOLOGY, INC.
$102
Alexion Pharmaceuticals, Inc.
$100
TESARO, Inc.
$95
AbbVie, Inc.
$95
SOBI, INC
$90
Ipsen Biopharmaceuticals, Inc
$88
SANOFI-AVENTIS U.S. LLC
$82
Eisai Inc.
$80
Karyopharm Therapeutics Inc.
$79
Pharmacyclics LLC, an AbbVie Company
$78
Seattle Genetics, Inc.
$72
Blueprint Medicines Corporation
$67
Kyowa Kirin, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$60
Dendreon Pharmaceuticals LLC
$59
Medtronic Vascular, Inc.
$57
Array BioPharma Inc.
$52
MorphoSys, US Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Puma Biotechnology, Inc.
$46
SERVIER PHARMACEUTICALS LLC
$46
Tempus AI, Inc
$44
TAIHO ONCOLOGY, INC.
$44
Genmab U.S., Inc.
$42
CSL Behring
$40
PORTOLA PHARMACEUTICALS, INC.
$40
Jazz Pharmaceuticals Inc.
$38
Deciphera Pharmaceuticals Inc.
$32
Myovant Sciences Inc.
$30
Servier Pharmaceuticals LLC
$29
G1 Therapeutics, Inc.
$29
AVEO Pharmaceuticals, Inc.
$29
CTI BioPharma Corp.
$28
Epizyme, Inc.,
$26
Fennec Pharmaceuticals, Inc.
$25
Myriad Genetic Laboratories, Inc.
$23
Lexicon Pharmaceuticals, Inc.
$23
MEDIVATION FIELD SOLUTIONS LLC
$23
EISAI INC.
$22
Legend Biotech USA Inc.
$22
PharmaEssentia USA Corporation
$21
Janssen Pharmaceuticals, Inc
$19
EUSA Pharma (US) LLC
$19
Stemline Therapeutics Inc.
$18
Ethicon US, LLC
$18
Apellis Pharmaceuticals, Inc.
$17
Taiho Oncology, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Hologic Sales and Service, LLC
$17
GE HealthCare
$16
Novocure Inc.
$16
ADC Therapeutics America, Inc.
$15
Aveo Pharmaceuticals, Inc.
$15
Global Blood Therapeutics, Inc.
$14
Sumitomo Pharma America, Inc.
$14
Shire North American Group Inc
$14
Aurobindo Pharma USA, Inc.
$13
Clovis Oncology, Inc.
$12
ADMA BioManufacturing LLC
$4
Emmaus Medical, Inc.
$3
Top 3 companies account for 40.0% of total payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BEVYXXA · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · COSELA · CYRAMZA · Cabometyx · Copiktra · Cotellic · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · Elahere · Empaveli · Endari · Enhertu · Epkinly · Erivedge · Erleada · FOTIVDA · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Marqibo · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Pedmark · Perjeta · Phesgo · Pomalyst · PreciseTumor · Prolia · QINLOCK · REBLOZYL · RYBREVANT · Reveal LINQ · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XERMELO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $54 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
41
Per 100K population
7.0
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Choksi is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (mixed engagement, top 13%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Choksi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Choksi performed 36,720 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choksi receive payments from pharmaceutical companies?
Yes. Dr. Choksi received a total of $34,283 from 97 companies across 1,153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choksi's costs compare to other hematologys in Trinity?
Dr. Choksi's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choksi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Trinity
Browse hematologys in Trinity ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
ImmunoGen, Inc. Payments to Doctors
See all physicians who received payments from ImmunoGen, Inc..
By company
Verastem, Inc. Payments to Doctors
See all physicians who received payments from Verastem, Inc..
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology